Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...] …
Blog Posts
340B drugs have steadily increased as a share of U.S. branded outpatient pharmaceutical sales and reached 18% of the total [...] …
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...] …
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …
On the final day of Missouri’s legislative session, lawmakers overwhelmingly passed a bill to bar drugmaker 340B contract pharmacy restrictions [...] …